South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded ...

The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...

South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded ...

South Africa has more people living with HIV than any other country, and US President Donald Trump’s aid freeze has hit ...

HIV vaccine has eluded scientists for decades Africa-led research project was fully funded by USAID South Africa a hub for research on HIV virus Trump assessing if aid consistent with ‘America ...

Because South Africa has the world's largest population of people living with HIV, at more than 8 million, it is a hub for research on the virus. "Most of the landmark and groundbreaking studies ...

Johannesburg: South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from USAID to ...

They are part of a wider South African-led HIV vaccine development scheme known as BRILLIANT and funded entirely by a US$45 million (S$60 million) grant from USAID. It is unclear if or when the ...

The development of a promising HIV vaccine led by South African researchers has been halted due to funding cuts from USAID, following U.S. President Donald Trump's policy changes. The vaccine program, ...